Glaxo Smith Kline 58160081811 Hiberix Haemophilus Influenzae Type b Vaccine (Hib) Indicated for People 6 Weeks Through 4 Years of Age 10 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL

HIBERIX is a vaccine indicated for active immunization for the prevention of invasive disease caused by Haemophilus influenzae type b
HIBERIX is approved for use in children 6 weeks through 4 years of age (prior to fifth birthday)
10 single dose vials of lyophilized vaccine
10 vials containing 0.85 mL of saline diluent
Packaged without syringes or needles

Manufacturer # 58160081811
Brand Hiberix®
Manufacturer Glaxo Smith Kline
Country of Origin Unknown
Application Haemophilus Influenzae Type b Vaccine (Hib)
Container Type Single-Dose Vial
Dosage Form Injection
Generic Drug Code 99298
Generic Drug Name Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate), Preservative Free
Is_Active_Vendor Y
Is_DSCSA Y
Is_Discontinued N
Is_Medical_Device Y
Lot_Tracking_Flag Y
NDC Number 58160081811
On_Allocation N
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Storage Requirements Requires Refrigeration
Strength 10 mcg / 0.5 mL
Supplier_ID 488095
Type Intramuscular
UNSPSC Code 51201627
User Indicated for People 6 Weeks Through 4 Years of Age
Volume 0.5 mL